Shenzhen Hybio Pharmaceutical: difference between revisions
Diff·revision 17 → 18·09:23, 10 Dec 2025
Difference between revision 17 and revision 18 of Shenzhen Hybio Pharmaceutical. 3 lines changed; the page grew by 136 bytes.
| Revision 17 — 17:15, 28 Nov 2025 BatchNumberBede (talk) expand §Corporate identity and history 12,130 bytes +1,064 | Revision 18 — 09:23, 10 Dec 2025 GastroparesisGwen (talk) correct the other-designations row — those are trading variants, not subsidiaries 12,266 bytes +136 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 968 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |